Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.

John G.F. Cleland, Andrew J.S. Coats, Ewa A. Jankowska et al. · PubMed · 2021 · 19.5K citations

Medicine, Cardiology, Internal Medicine +12

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

European Heart Journal · 2016 · 11.5K citations · Full text

Medicine, Cardiology, Internal Medicine +16

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure

Jay N. Cohn, T. Barry Levine, Maria Teresa Olivari et al. · New England Journal of Medicine · 1984 · 3.1K citations

Medicine, Cardiology, Clinical Cardiology +9

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

Michele Brignole, Angelo Auricchio, Gonzalo Barón‐Esquivias et al. · European Heart Journal · 2013 · 2.8K citations · Full text

Medicine, Cardiology, Cardiothoracic Surgery +5

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

Julian D. Gillmore, Rodney H. Falk, Giampaolo Merlini et al. · Circulation · 2016 · 2K citations · Full text

Medicine, Cardiology, Nuclear Medicine +14